No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
No Data
Earnings Preview: NeoGenomics to Report Financial Results Post-market on July 29
NeoGenomics (NASDAQ:NEO) Shareholders Have Endured a 68% Loss From Investing in the Stock Three Years Ago
Is NeoGenomics, Inc. (NEO) the Most Profitable Stock of the Last 20 Years?
Express News | Neogenomics Inc : Leerink Partners Cuts Target Price to $27 From $28
NeoGenomics's Growth and Resilience Affirm Buy Rating: Analyst Puneet Souda's Perspective
NeoGenomics to Report Second Quarter 2024 Financial Results on July 29, 2024